SV

Street Verdict

Analyst Scorecard

A record of what Sneha Poddar said publicly, with the source. Not advice.

“Bearish on the Pharma sector in the near term, expecting time correction due to high valuations, especially for CDMO players that have already seen a significant run-up, and ongoing uncertainty regarding tariff announcements. However, any correction or extended consolidation would present long-term accumulation opportunities for CDMO players like Laurus Labs, Biocon, and Divi’s, given their strong pipelines and global opportunities.”

Sneha Poddar’s track record (trackable calls only): 5 graded calls · 95% CI 4–62%

Nifty PharmaBearishCalled 21 Aug 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Sneha Poddar’s full track record